Lewis & Clark Plant Sciences Fund I, LP - Jul 24, 2023 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role: Member of 13D group
Signature: /s/ Larry Page, Managing Director of Lewis & Clark Plant Sciences Fund I, LP
Stock symbol: GRNA
Transactions as of: Jul 24, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/26/2023, 05:21 PM
Previous filing: Jun 8, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRNA	Common Stock, par value $0.0001 per share	Other		-1.82M	-100%		0	Jul 24, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting Person contributed its shares of common stock to SW ParentCo, Inc. ("Parent") in exchange for shares of Series A-2 Preferred Stock, par value $0.001 per share, of Parent pursuant to the Contribution and Exchange Agreement dated May 29, 2023, between Reporting Person and Parent in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger among Issuer, Parent and SW MergerCo, Inc. ("Merger Sub") on July 24, 2023, pursuant to which Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent.

Content

Reporting Person contributed its shares of common stock to SW ParentCo, Inc. ("Parent") in exchange for shares of Series A-2 Preferred Stock, par value $0.001 per share, of Parent pursuant to the Contribution and Exchange Agreement dated May 29, 2023, between Reporting Person and Parent in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger among Issuer, Parent and SW MergerCo, Inc. ("Merger Sub") on July 24, 2023, pursuant to which Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent.